• Publications
  • Influence
Chronic graft-versus-host disease complicated by membranous glomerulonephritis.
Key words: graft-versus-host disease; nephrotic administered for GVHD prophylaxis from day −1 to syndrome day +180. Ten-months after alloHSCT, a mucosal ulceration and dryness in her mouth wasExpand
  • 48
  • 3
The comparison of gonadotropin-releasing hormone agonist therapy and intraperitoneal Ringer's lactate solution in prevention of postoperative adhesion formation in rat models.
OBJECTIVE To evaluate gonadotropin-releasing hormone agonists (GnRH-a) therapy and intraperitoneal Ringer's lactate solution (RL) for the prevention of postsurgical adhesion formation in rat models.Expand
  • 21
Relationship between endomyometritis and the duration of premature membrane rupture.
In this study, correlation between duration of premature rupture of the membranes (PROM) and the degree of membrane, decidua, and myometrium infections were histologically investigated. The study wasExpand
  • 13
Effects of Seprafilm (sodium hyaluranate-based bioresorbable), Sepracoat (0.4% hyaluronic acid), and Ringer's lactate on the prevention of postsurgical adhesion formation in rat models.
Forty adult female rats were randomly divided into four groups. Before the standard surgical procedure which consisted of creating a lesion with a lancet over the right uterine horn. Group I receivedExpand
  • 13
Antibiotics prophylaxis in laparoscopy.
OBJECTIVE This study was to determine which prophylactic antibiotic regimen is most effective in reducing the incidence of infectious morbidity in women undergoing laparoscopy. DESIGN Randomized,Expand
  • 13
Beta-thalassemia: early antenatal diagnosis.
Treatment of chronic anovulation resistant to clomiphene citrate (CC) by using gonadotrophin-releasing hormone agonist (GnRH-a) ovarian suppression followed by recombinant follicle-stimulating
We performed a prospective study to assess the effects of a starting dose of 50 units of recombinant follicle stimulating hormone (Puregon) during gonadotrophin-releasing hormone agonist therapyExpand